Get ready to chat with a groundbreaking chatbot that takes the lead in assisting you. Incorporating automation into the informed consent process for genomics research studies expands its scope and enhances comprehension, resulting in broader outreach and improved understanding.

 Experience the power of a groundbreaking chatbot that automates the informed consent process for genomics research studies, leading to broader outreach, improved comprehension, and enhanced understanding.

Professor Eric Vilain, from the University of California, Irvine, will present groundbreaking research at the European Society of Human Genetics annual conference, highlighting the potential of a chatbot called GIA (Genetics Information Assistant) in revolutionizing the informed consent process in biomedical research. The study shows that incorporating the chatbot in the consent process promotes inclusivity, accelerates completion, and achieves high levels of understanding. 

By transforming the trial consent form and protocol into a logical script, the chatbot engages participants, assesses their knowledge, and can be accessed at any time, eliminating the time constraints of traditional consent methods. The research team involved 72 families, with the chatbot users experiencing shorter consent conversations (44 minutes versus 76 minutes) and faster completion (five days versus 16 days) compared to those using traditional methods. 

The chatbot also demonstrated a high level of understanding among participants, with 96% passing a quiz and 86% reporting a positive experience. The study showcases the potential of chatbot technology to enhance the informed consent process, leading to more efficient and effective research participation.